PMCPA Case
| Case | AUTH/2933/2/17 |
| Parties | Health professional consultant to a pharmaceutical company (private complaint; Novartis named) v Chiesi Limited |
| Product | Fostair (beclomethasone and formoterol), NEXThaler device |
| Material | Online/digital banner advertisement (ref CHNEX20161340 Dec 16) and related PI on Chiesi respiratory website |
| Main issue | “Efficacy with only 3 steps per inhalation” claim vs SPC/PIL instructions; allegation of out-of-date PI (pneumonia warning) |
| Applicable Code year | 2016 |
| Complaint received | 08 February 2017 |
| Case completed | 02 May 2017 |
| Breach clauses | 7.2 |
| No breach clauses | 2, 4.1, 9.1 |
| Sanction | Undertaking received |
| Appeal | No appeal |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.